Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 1, 2017 – The FDA approved new updates to the Warnings and Precautions section of the Unituxin (dinutuximab) drug label.
Download PDF
Return to publications
